Product Information
PITAVASTATIN 2 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.9865 per EA under NDC 72603047901. Its NADAC has been published 69 times since Apr 30, 2025.
FDA first approved this application on Apr 30, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the pitavastatin calcium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2.09 mg/1
Manufacturer
NorthStar Rx LLCNDC
72603047901
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PITAVASTATIN CALCIUMApproval Type
Generic (ANDA)
FDA Application
ANDA205977FDA Approved
4/30/2024
TE Code
AB
On Market Since
12/1/2024
Pharmacological Classes
Price Statistics
The NADAC for PITAVASTATIN 2 MG TABLET has been published 69 times since Apr 30, 2025, and over the history we have for it it has declined 35.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9865 per EA |
|---|---|
| All-time high | $1.5515 (Jul 16, 2025) |
| All-time low | $0.9865 (Aug 19, 2026) |
| 52-week high | $1.4992 |
| 52-week low | $0.9865 |
| Median price | $1.3312 |
| Average price | $1.3460 |
| Largest weekly change | -10.2% (Jul 22, 2026) |
| Weeks tracked | 69 |
| Tracking since | Apr 30, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PITAVASTATIN 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PITAVASTATIN 2 MG TABLET, manufactured by NorthStar Rx LLC, is $0.9865 per EA (NDC 72603047901), effective Aug 19, 2026.
How has the price of PITAVASTATIN 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for PITAVASTATIN 2 MG TABLET has declined 35.5%. It has been tracked across 69 weekly CMS publications since Apr 30, 2025.
What are the highest and lowest recorded NADAC prices for PITAVASTATIN 2 MG TABLET?
Since Apr 30, 2025, the NADAC for PITAVASTATIN 2 MG TABLET has ranged from a low of $0.9865 (Aug 19, 2026) to a high of $1.5515 (Jul 16, 2025), with a median of $1.3312 per EA.
Are there cheaper alternatives to PITAVASTATIN 2 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PITAVASTATIN 2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PITAVASTATIN 2 MG TABLET?
PITAVASTATIN 2 MG TABLET (NDC 72603047901) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.